Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in Deuterium Concentration. | Int J Mol Sci | 2025 | 41303451 | PubTator, text mining | PubMed |
| Identification of tumor initiating cells and early marker genes in normal colonic epithelium that lead to neoplastic transformation. | Res Sq | 2025 | 41282138 | PubTator, text mining | PubMed |
| THBS1high macrophages promote aortic aneurysm formation by orchestrating an inflammatory and smooth muscle cell phenotypic transition program in vascular Behçet's disease. | BMC Med | 2025 | 41225543 | PubTator, text mining | PubMed |
| Targeting the ac4C 'Writer' NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells. | Cell Death Dis | 2025 | 41203621 | PubTator, text mining | PubMed |
| ETS1 suppresses hepatic stellate cell activation and liver fibrosis. | JCI Insight | 2025 | 41196693 | PubTator, text mining | PubMed |
| Deciphering the Tenascin-C Nexus: A Comprehensive Review of Its Involvement in Chronic Respiratory Diseases. | Pathophysiology | 2025 | 40981103 | PubTator, text mining | PubMed |
| ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway. | PLoS One | 2025 | 40938895 | PubTator, text mining | PubMed |
| Role of ETS2 gene in inflammatory bowel disease: A narrative review. | Medicine (Baltimore) | 2025 | 40922284 | PubTator, text mining | PubMed |
| A stem cell differentiation model reveals two alternative fates in CBFA2T3::GLIS2-driven acute megakaryoblastic leukemia initiation. | Commun Biol | 2025 | 40866546 | PubTator, text mining | PubMed |
| The m6A modification-mediated upregulation of ETS2 translation drives arsenic-induced spermatogonial senescence. | Free Radic Biol Med | 2025 | 40865778 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer. | NPJ Breast Cancer | 2025 | 40858590 | PubTator, text mining | PubMed |
| The pivotal regulatory role of the FEV-SLC7A11 axis in ferroptosis elucidates the anti-aging mechanism of β-sitosterol in a cross-species study. | Front Pharmacol | 2025 | 40852608 | PubTator, text mining | PubMed |
| Genetics and Vitamin D Interactions in Osteoporosis: A Path to Precision Medicine. | J Cell Mol Med | 2025 | 40831018 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis. | Signal Transduct Target Ther | 2025 | 40804233 | PubTator, text mining | PubMed |
| PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway. | Front Immunol | 2025 | 40746562 | PubTator, text mining | PubMed |
| circ-miR-524 accelerates the growth of liver cancer cells by inducing DNA damage repair through K-RAS. | Genes Dis | 2025 | 40740194 | PubTator, text mining | PubMed |
| Identification of functional non-coding variants associated with orofacial cleft. | Nat Commun | 2025 | 40670354 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental studies reveal KPNA2 as a novel biomarker of hepatocellular carcinoma progression and telomere maintenance. | Eur J Med Res | 2025 | 40665355 | PubTator, text mining | PubMed |
| Identification of markers for neurescence through transcriptomic profiling of postmortem human brains. | NPJ Aging | 2025 | 40595771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=3